6BGT
Structure of Trastuzumab Fab mutant in complex with Her2 extracellular domain
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-04-11 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.9536 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 62.860, 114.460, 204.279 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 49.927 - 2.700 |
R-factor | 0.207 |
Rwork | 0.205 |
R-free | 0.24750 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1n8z |
RMSD bond length | 0.005 |
RMSD bond angle | 0.831 |
Data reduction software | MOSFLM |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX ((1.10.1_2155: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 53.200 | 2.810 |
High resolution limit [Å] | 2.700 | 2.700 |
Number of reflections | 41043 | |
<I/σ(I)> | 12.7 | |
Completeness [%] | 99.0 | |
Redundancy | 10.1 | |
CC(1/2) | 0.998 | 0.909 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 6.5 | 293 | 100 mM MES, pH 6.5, 18% PEG3350, 10% glycerol |